6 resultater
BACKGROUND OF THE INVENTION
Throughout this application various publications are referenced and citations provided for them. The disclosure of these publications in their entireties are hereby incorporated by reference into this application to more fully describe the state of the art to which this
FIELD OF THE INVENTION
The present invention relates to the inhibition of cancer cell growth, proliferation, and metastasis by contacting cells with an N,N'-dibenzyl-.alpha.,.omega.-diaminoalkane. More specifically, the present invention relates to the treatment of cancer in humans by administration
BACKGROUND OF THE INVENTION
The application of positron emission tomography (PET) to the study of human tumors and to the study of the response of such tumors to different therapeutic approaches continues to be of interest. Of particular interest are studies where valid tracer kinetic models exist
BACKGROUND OF THE INVENTION
Reference is made to Applicant's co-pending applications, Ser. No. 820,517, filed Jan. 17, 1986 and Ser. No. 002,890, filed Jan. 13, 1987.
FIELD OF THE INVENTION
The present invention relates to improved formulations and methods for the detection of malignant disease in a
BACKGROUND OF THE INVENTION
The present application is a continuation-in-part of Ser. No. 820,517, filed Jan. 17, 1986.
1. FIELD OF THE INVENTION
The present invention relates to improved formulations and methods for the detection of malignant disease in a patient. More particularly, the present
1. Field of the Invention
The present invention relates to improved formulations and methods for the detection of malignant disease in a patient. More particularly, the present invention is directed to formulations which augment tumor related increases in a patient's polyamine level and which